Nimer SD - Search Results

1

The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation.

Wang L, Gural A, Sun XJ, Zhao X, Perna F, Huang G, Hatlen MA, Vu L, Liu F, Xu H, Asai T, Xu H, Deblasio T, Menendez S, Voza F, Jiang Y, Cole PA, Zhang J, Melnick A, Roeder RG, Nimer SD. Wang L, et al. Among authors: nimer sd. Science. 2011 Aug 5;333(6043):765-9. doi: 10.1126/science.1201662. Epub 2011 Jul 14. Science. 2011. PMID: 21764752 Free PMC article.

2

The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.

Frank R, Zhang J, Uchida H, Meyers S, Hiebert SW, Nimer SD. Frank R, et al. Among authors: nimer sd. Oncogene. 1995 Dec 21;11(12):2667-74. Oncogene. 1995. PMID: 8545124

3

Adjacent, cooperative elements form a strong, constitutive enhancer in the human granulocyte-macrophage colony-stimulating factor gene.

Nimer SD, Zhang W, Kwan K, Whang Y, Zhang J. Nimer SD, et al. Blood. 1996 May 1;87(9):3694-703. Blood. 1996. PMID: 8611694 Free article.

4

Transcriptional regulation of interleukin-3 expression in megakaryocytes.

Nimer S, Zhang J, Avraham H, Miyazaki Y. Nimer S, et al. Blood. 1996 Jul 1;88(1):66-74. Blood. 1996. PMID: 8704203 Free article.

5

MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties.

Miyazaki Y, Sun X, Uchida H, Zhang J, Nimer S. Miyazaki Y, et al. Oncogene. 1996 Oct 17;13(8):1721-9. Oncogene. 1996. PMID: 8895518

6

The AML1/ETO fusion protein activates transcription of BCL-2.

Klampfer L, Zhang J, Zelenetz AO, Uchida H, Nimer SD. Klampfer L, et al. Among authors: nimer sd. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14059-64. doi: 10.1073/pnas.93.24.14059. Proc Natl Acad Sci U S A. 1996. PMID: 8943060 Free PMC article.

7

AML1A and AML1B can transactivate the human IL-3 promoter.

Uchida H, Zhang J, Nimer SD. Uchida H, et al. Among authors: nimer sd. J Immunol. 1997 Mar 1;158(5):2251-8. J Immunol. 1997. PMID: 9036972

8

Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter.

Uchida H, Downing JR, Miyazaki Y, Frank R, Zhang J, Nimer SD. Uchida H, et al. Among authors: nimer sd. Oncogene. 1999 Jan 28;18(4):1015-22. doi: 10.1038/sj.onc.1202383. Oncogene. 1999. PMID: 10023677

9

Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias.

Mao S, Frank RC, Zhang J, Miyazaki Y, Nimer SD. Mao S, et al. Among authors: nimer sd. Mol Cell Biol. 1999 May;19(5):3635-44. doi: 10.1128/MCB.19.5.3635. Mol Cell Biol. 1999. PMID: 10207087 Free PMC article.

10

The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.

Frank RC, Sun X, Berguido FJ, Jakubowiak A, Nimer SD. Frank RC, et al. Among authors: nimer sd. Oncogene. 1999 Mar 4;18(9):1701-10. doi: 10.1038/sj.onc.1202459. Oncogene. 1999. PMID: 10208431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters